Stephanie Hachtel

This inventor holds 21 USPTO granted patents and 1 published patent application, plus 7 CIPO patents and 20 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Sanofi, Sanofi-A Ventis Deutschland Gmbh, Sanofi-Aventis. Active years: 2010-2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Stephanie Hachtel. Retrieved from https://idiyas.com/inventor/stephanie-hachtel

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 21 (Patent Applications = 1)

% Patents Active = 47.6

CIPO Patents = 7 (Patent Applications = 1)

EPO Patents = 20 (Patent Applications = 14)

Average Co-Inventor Count = 6.7

ph-index = 3

Forward Citations = 56(Granted Patents)

Company Filing History:

Sanofi-A Ventis Deutschland Gmbh

Years Active: 2010-2016

Loading Chart...

Areas of Expertise:

CXCR2 Inhibitors

Carboxylic Acid Derivatives

Oxazolopyrimidine

Kinase Inhibitors

Heterocyclic Compounds

Benzoimidazole

Piperidinesulfonylureas

Pharmaceutical Compositions

APJ Receptor Modulators

Pyrazolo Compounds

Heterocycles

Peroxisome Proliferator

21 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9321787 - Carboxylic acid derivatives having an oxazolo[5,4-d]pyrimidine ring (2016-04-26),

2. 9156796 - Benzoimidazole-carboxylic acid amide derivatives as APJ receptor modulators (2015-10-13),

3. 9133181 - Substituted 6-(4-hydroxy-phenyl)-1H-pyrazolo[3,4-b]pyridine derivatives as kinase inhibitors (2015-09-15),

4. 9040544 - 2,5-substituted oxazolopyrimidine derivatives (2015-05-26),

5. 8980938 - CXCR2 inhibitors (2015-03-17),

6. 8907093 - Carboxylic acid derivatives having an oxazolo[4,5-c]pyridine ring (2014-12-09),

7. 8846692 - Carboxylic acid derivatives having a 2,5-substituted oxazolopyrimidine ring (2014-09-30),

8. 8846691 - Heterocyclic carboxylic acid derivatives having a 2,5,7-substituted oxazolopyrimidine ring (2014-09-30),

9. 8846690 - Heterocyclic carboxylic acid derivatives having a 2,5-substituted oxazolopyrimidine ring (2014-09-30),

10. 8785439 - 2,5,7-substituted oxazolopyrimidine derivatives (2014-07-22),

11. 8748436 - Carboxylic acid derivatives having a 2,5,7-substituted oxazolopyrimidine ring (2014-06-10),

12. 8735402 - Cycloalkyloxycarboxylic acid derivatives (2014-05-27),

13. 8686150 - 6-(4-hydroxy-phenyl)-3-alkyl-1H-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors (2014-04-01),

14. 8642643 - CXCR2 antagonists (2014-02-04),

15. 8586612 - Piperidinesulfonylureas and -thioureas, their preparation, their use and pharmaceutical compositions comprising them (2013-11-19),

Title: Stephanie Hachtel: Innovator in Pharmaceutical Patents

Introduction

Stephanie Hachtel, located in Frankfurt am Main, Germany, is an accomplished inventor holding an impressive portfolio of 21 patents. Her work primarily focuses on innovative compounds that have significant applications in pharmaceuticals, particularly in the fields of wound healing and hypertension treatment.

Latest Patents

Among her recent patents, Hachtel has developed carboxylic acid derivatives featuring an oxazolo[5,4-d]pyrimidine ring. These compounds are specifically designed to aid in wound healing, showcasing her commitment to advancing medical technologies. Additionally, she has created benzoimidazole-carboxylic acid amide derivatives that serve as APJ receptor modulators. These compounds are of particular importance in treating diseases related to increased blood pressure, and they also have potential applications as active ingredients in pharmaceutical compositions.

Career Highlights

Stephanie Hachtel has made a significant impact in the pharmaceutical field, working with notable companies such as Sanofi and Sanofi-Aventis Deutschland GmbH. Her contributions to these organizations underline her expertise and dedication to innovation in therapeutic solutions.

Collaborations

During her career, Hachtel has collaborated with esteemed colleagues, including Dieter Kadereit and Matthias Schaefer. These partnerships have likely influenced the advancement of her projects and the development of groundbreaking technologies in her area of expertise.

Conclusion

Stephanie Hachtel exemplifies the spirit of innovation in the pharmaceutical industry. Through her numerous patents and collaborations, she continues to contribute valuable knowledge and advancements in medical treatments, making a lasting impact on healthcare.

Profile summary based on public USPTO records.